BHCHXETF / FundBaron Health Care Fund
Verdicts genuinely change. Free email alert the moment BHCHX's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Baron Health Care Fund · BARON SELECT FUNDS
43 holdings
NON-COMPLIANT 12.98% of portfolio weight is in non-compliant holdings, over the 5% threshold.
43 holdings, 32 matched (82% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
6.51% of this portfolio’s income is non-permissible — weighted across holdings, computed over 75% of portfolio weight (29 of 43 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
67.0% compliant 0.0% questionable 13.0% non-compliant 17.7% unscreened
All holdings (43)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 13.66% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| MTD Mettler-Toledo International Inc | COMPLIANT | 5.60% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| JNJ Johnson & Johnson | COMPLIANT | 5.56% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| ARGX Argenx SE | COMPLIANT | 4.23% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 3.91% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| Roivant Sciences Ltd | UNSCREENED | 3.88% | no in-house ratios for this holding |
| Teva Pharmaceutical Industries Ltd | UNSCREENED | 3.86% | no in-house ratios for this holding |
| WELL Welltower Inc | COMPLIANT | 3.38% | AAOIFI10.6% Usmani26.7% Dow Jones Islamic15.6% S&P Shariah19.1% MSCI Islamic26.7% MSCI Islamic M-Series19.1% FTSE Shariah26.7% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 3.28% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| RadNet Inc | UNSCREENED | 3.24% | no in-house ratios for this holding |
| BLLN Billiontoone Inc | COMPLIANT | 2.84% | AAOIFI3.1% Usmani19.7% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic19.6% MSCI Islamic M-Seriespass FTSE Shariah12.5% |
| EW Edwards Lifesciences Corp | COMPLIANT | 2.64% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 2.61% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| AZN AstraZeneca PLC | COMPLIANT | 2.49% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| MRK Merck & Co Inc | COMPLIANT | 2.48% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| GH Guardant Health Inc | COMPLIANT | 2.17% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| MDGL Madrigal Pharmaceuticals Inc | COMPLIANT | 2.12% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| Revolution Medicines Inc | UNSCREENED | 2.05% | no in-house ratios for this holding |
| ELAN Elanco Animal Health Inc | NON_COMPLIANT | 2.05% | AAOIFI31.2% Usmani27.5% Dow Jones Islamic41.7% S&P Shariah45.2% MSCI Islamic27.5% MSCI Islamic M-Series45.2% FTSE Shariah27.5% |
| KYMR Kymera Therapeutics Inc | NON_COMPLIANT | 2.01% | AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0% |
| GILD Gilead Sciences Inc | COMPLIANT | 1.99% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| NTRA Natera Inc | COMPLIANT | 1.93% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| ISRG Intuitive Surgical Inc | COMPLIANT | 1.74% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| PTGX Protagonist Therapeutics Inc | NON_COMPLIANT | 1.72% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ELV Elevance Health Inc | NON_COMPLIANT | 1.69% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| RGEN Repligen Corp | COMPLIANT | 1.49% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| Xenon Pharmaceuticals Inc | UNSCREENED | 1.32% | no in-house ratios for this holding |
| HTFL HeartFlow Inc | COMPLIANT | 1.26% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 1.25% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| IDXX IDEXX Laboratories Inc | COMPLIANT | 1.20% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| DXCM Dexcom Inc | COMPLIANT | 1.18% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| VeraDermics Inc | UNSCREENED | 1.08% | no in-house ratios for this holding |
| Insmed Inc | UNSCREENED | 0.93% | no in-house ratios for this holding |
| ARQT Arcutis Biotherapeutics Inc | COMPLIANT | 0.80% | AAOIFI3.8% Usmani23.4% Dow Jones Islamic5.0% S&P Shariah6.5% MSCI Islamic23.4% MSCI Islamic M-Series6.5% FTSE Shariah22.3% |
| DIM.PA Sartorius Stedim Biotech | COMPLIANT | 0.73% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| AXSM Axsome Therapeutics Inc | COMPLIANT | 0.64% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| CYTK Cytokinetics Inc | NON_COMPLIANT | 0.63% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| Definium Therapeutics Inc | UNSCREENED | 0.57% | no in-house ratios for this holding |
| ASND Ascendis Pharma A/S | COMPLIANT | 0.35% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TNGX Tango Therapeutics Inc | NON_COMPLIANT | 0.34% | AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic3.0% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| Abivax SA | UNSCREENED | 0.29% | no in-house ratios for this holding |
| Newamsterdam Pharma Co NV | UNSCREENED | 0.27% | no in-house ratios for this holding |
| Enliven Therapeutics Inc | UNSCREENED | 0.22% | no in-house ratios for this holding |
The published standards disagree about this fund by 39 points of portfolio weight — 58.6% of it passes AAOIFI, 19.6% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 58.6% ratios fail on 9.4% 29.7% not rated under AAOIFI
ratios pass on 21.5% ratios fail on 40.3% 35.9% not rated under Usmani
ratios pass on 58.3% ratios fail on 9.7% 29.7% not rated under Dow Jones Islamic
ratios pass on 58.3% ratios fail on 9.7% 29.7% not rated under S&P Shariah
ratios pass on 19.6% ratios fail on 49.0% 29.1% not rated under MSCI Islamic
ratios pass on 58.3% ratios fail on 9.7% 29.7% not rated under MSCI Islamic M-Series
ratios pass on 25.6% ratios fail on 39.6% 32.5% not rated under FTSE Shariah
32 of 43 listed holdings carry our own per-methodology verdicts (80% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 28 (72% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 3.28% |
| ELAN Elanco Animal Health Inc | 2.05% |
| KYMR Kymera Therapeutics Inc | 2.01% |
| PTGX Protagonist Therapeutics Inc | 1.72% |
| ELV Elevance Health Inc | 1.69% |
| IONS Ionis Pharmaceuticals Inc | 1.25% |
| CYTK Cytokinetics Inc | 0.63% |
| TNGX Tango Therapeutics Inc | 0.34% |
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Baron Health Care Fund (BHCHX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Screened on its holdings, not its name
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYEli Lilly & Co | 13.66% | Compliant |
| MTDMettler-Toledo International Inc | 5.60% | Compliant |
| JNJJohnson & Johnson | 5.56% | Compliant |
| ARGXArgenx SE | 4.23% | Compliant |
| TMOThermo Fisher Scientific Inc | 3.91% | Compliant |
| Roivant Sciences Ltdnot matched to a ticker | 3.88% | Not screened |
| Teva Pharmaceutical Industries Ltdnot matched to a ticker | 3.86% | Not screened |
| WELLWelltower Inc | 3.38% | Compliant |
| UNHUnitedHealth Group Inc | 3.28% | Non-compliant |
| RadNet Incnot matched to a ticker | 3.24% | Not screened |
Top 10 of 43 holdings, 50.6% of the fund by weight. Every holding is screened, not only these.
What holds the number back
The positions keeping this fund short of 100% compliant by weight.
- Roivant Sciences Ltdnot screened3.88%
- Teva Pharmaceutical Industries Ltdnot screened3.86%
- UNHnon-compliant3.28%
- RadNet Incnot screened3.24%
- Revolution Medicines Incnot screened2.05%
- ELANnon-compliant2.05%
What changed, and when
Verdict history for BHCHX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for BHCHX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
ℹ️ no compliance scan has run for 2 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 66.20 | NEUTRAL |
| Stochastic %K (14) | 100.00 | SELL |
| CCI (20) | 132.88 | SELL |
| Williams %R (14) | 0.00 | SELL |
| MACD (12,26,9) | 0.09 | BUY |
| ROC (10) | 5.38 | BUY |
| Momentum (10) | 1.28 | BUY |
| EMA (10) | 24.53 | BUY |
| SMA (10) | 24.54 | BUY |
| EMA (20) | 24.13 | BUY |
| SMA (20) | 24.02 | BUY |
| EMA (30) | 23.87 | BUY |
| SMA (30) | 23.59 | BUY |
| EMA (50) | 23.51 | BUY |
| SMA (50) | 23.34 | BUY |
| EMA (100) | 22.86 | BUY |
| SMA (100) | 22.90 | BUY |
| EMA (200) | 21.97 | BUY |
| SMA (200) | 21.50 | BUY |
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.